{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:29:11Z","timestamp":1761823751654,"version":"build-2065373602"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.canrad.2015.04.004","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T13:00:35Z","timestamp":1437915635000},"page":"322-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["R\u00e9sultats \u00e0 long terme de la chimioradioth\u00e9rapie n\u00e9oadjuvante des cancers de l\u2019\u0153sophage\u00a0: \u00e9tude r\u00e9trospective monocentrique sur 102\u00a0patients"],"prefix":"10.1016","volume":"19","author":[{"given":"A.","family":"Ruffier-Loubi\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Janoray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chapet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"de Calan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9.","family":"Dorval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Orain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Calais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2015.04.004_bib0005","first-page":"721","article-title":"A multi-ethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States)","volume":"12","author":"Wu","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canrad.2015.04.004_bib0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0015","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/j.seminoncol.2004.04.021","article-title":"Epidemiology of upper gastrointestinal malignancies","volume":"31","author":"Crew","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0020","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0399-8320(05)82124-4","article-title":"Donn\u00e9es r\u00e9centes sur l\u2019\u00e9pid\u00e9miologie du cancer de l\u2019\u0153sophage","volume":"29","author":"Faivre","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0025","first-page":"228","article-title":"Management and prognosis of esophageal cancers: has progress been made?","volume":"42","author":"Bouvier","year":"2006","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.canrad.2015.04.004_bib0030","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"Enzinger","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0035","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1470-2045(07)70172-9","article-title":"Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities","volume":"8","author":"Mariette","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0959-8049(09)70086-3","article-title":"Current standards and options in the treatment of squamous cell oesophageal carcinoma","volume":"45","author":"Mariette","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.canrad.2015.04.004_bib0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0360-3016(97)00569-5","article-title":"Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group)","volume":"41","author":"Arnott","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.04.004_bib0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1741-7015-2-35","article-title":"Gastrointestinal cancer disease site group of cancer care Ontario's program in evidence-based care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis","volume":"2","author":"Malthaner","year":"2004","journal-title":"BMC Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0055","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0060","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2006.10.4760","article-title":"Long-term results of RTOG trial\u00a08911 (USA Intergroup\u00a0113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer","volume":"25","author":"Kelsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0065","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial","volume":"359","author":"Medical Research Council Oesophageal Cancer Working Group","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2015.04.004_bib0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199707173370304","article-title":"Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus","volume":"337","author":"Bosset","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0075","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1278-3218(99)80019-5","article-title":"La chimioth\u00e9rapie n\u00e9oadjuvante a-t-elle une place dans le traitement \u00e0 vis\u00e9e curative du cancer \u00e0 un stade local ou locor\u00e9gional\u00a0?","volume":"2","author":"Droz","year":"1998","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.04.004_bib0080","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1200\/JCO.2014.55.9070","article-title":"Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction","volume":"32","author":"Davies","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","article-title":"Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis","volume":"8","author":"Gebski","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0090","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0095","doi-asserted-by":"crossref","first-page":"98s","DOI":"10.1016\/S1278-3218(01)80014-7","article-title":"Ad\u00e9nocarcinome du bas \u0153sophage et du cardia\u00a0: prise en charge non chirurgicale","volume":"5","author":"Maingon","year":"2001","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.04.004_bib0100","first-page":"CD002092","article-title":"Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus","author":"Wong","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.canrad.2015.04.004_bib0105","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","article-title":"Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD\u00a09102","volume":"25","author":"Bedenne","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0110","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/gut.2003.025080","article-title":"Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis","volume":"53","author":"Fiorica","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.canrad.2015.04.004_bib0115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9610(03)00066-7","article-title":"A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer","volume":"185","author":"Urschel","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.canrad.2015.04.004_bib0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.critrevonc.2009.11.007","article-title":"Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy","volume":"75","author":"Cr\u00e9hange","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"year":"1993","series-title":"ICRU report\u00a050: prescribing, recording and reporting photon beam therapy","author":"International Commission on Radiation Units and Measurements","key":"10.1016\/j.canrad.2015.04.004_bib0125"},{"year":"1999","series-title":"ICRU report\u00a062. Prescribing, recording and reporting photon beam therapy. Supplement to ICRU report 50. Bethesda MD: ICRU","author":"International Commission on Radiation Units and Measurements","key":"10.1016\/j.canrad.2015.04.004_bib0130"},{"key":"10.1016\/j.canrad.2015.04.004_bib0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0021-9681(78)90043-7","article-title":"Estimation of confidence limits for the cumulative probability of survival in life table analysis","volume":"31","author":"Rothman","year":"1978","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.canrad.2015.04.004_bib0140","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0145","first-page":"391","article-title":"A prospective study of combined therapy in esophageal cancer","volume":"41","author":"Apinop","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.canrad.2015.04.004_bib0150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1200\/JCO.2001.19.2.305","article-title":"Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma","volume":"19","author":"Urba","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0155","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0160","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/annonc\/mdh219","article-title":"A single institutional phase\u00a0III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma","volume":"15","author":"Lee","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0165","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase\u00a0III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB\u00a09781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0170","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1200\/jco.2010.28.15_suppl.4005","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase\u00a0III trial FFCD 9901","volume":"28","author":"Mariette","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase\u00a0III trial","volume":"6","author":"Burmeister","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0180","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.21850","article-title":"The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas","volume":"106","author":"Br\u00fccher","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2015.04.004_bib0185","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.sla.0000186170.38348.7b","article-title":"Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification","volume":"242","author":"Schneider","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2015.04.004_bib0190","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.athoracsur.2008.11.001","article-title":"Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival","volume":"87","author":"Donahue","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.canrad.2015.04.004_bib0195","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/BF02067069","article-title":"Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer","volume":"16","author":"Nygaard","year":"1992","journal-title":"World J Surg"},{"key":"10.1016\/j.canrad.2015.04.004_bib0200","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/1097-0142(19940401)73:7<1779::AID-CNCR2820730702>3.0.CO;2-T","article-title":"A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus","volume":"73","author":"Le Prise","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2015.04.004_bib0205","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/SLA.0b013e3181fb8dde","article-title":"A multicenter study of survival after neoadjuvant radiotherapy\/chemotherapy and esophagectomy for ypT0N0M0R0\u00a0esophageal cancer","volume":"252","author":"Vallb\u00f6hmer","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.canrad.2015.04.004_bib0210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1200\/JCO.2006.08.0101","article-title":"American joint committee on cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma","volume":"25","author":"Rizk","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0215","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1200\/JCO.2005.05.017","article-title":"Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival","volume":"23","author":"Berger","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2006.01.009","article-title":"Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response","volume":"78","author":"Geh","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0225","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11307-005-0017-0","article-title":"Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer","volume":"7","author":"Lowe","year":"2005","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0038-1625303","article-title":"[18F-Deoxyglucose PET for the staging of oesophageal cancer: influence of histopathological subtype and tumour grading]","volume":"42","author":"Menzel","year":"2003","journal-title":"Nukl Nucl Med"},{"key":"10.1016\/j.canrad.2015.04.004_bib0235","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2000.18.18.3202","article-title":"Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma","volume":"18","author":"Flamen","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0240","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/sj.bjc.6603412","article-title":"(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response","volume":"95","author":"Gillham","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2015.04.004_bib0245","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijrobp.2007.03.053","article-title":"Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma","volume":"69","author":"Konski","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2015.04.004_bib0250","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.20585","article-title":"2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma","volume":"101","author":"Swisher","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2015.04.004_bib0255","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.canrad.2008.05.005","article-title":"Faut-il encore op\u00e9rer les cancers de l\u2019\u0153sophage localement \u00e9volu\u00e9s\u00a0?","volume":"12","author":"Hennequin","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.04.004_bib0260","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1477-7819-5-97","article-title":"Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation","volume":"5","author":"Gillham","year":"2007","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0265","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1158\/1535-7163.MCT-06-0351","article-title":"Pretherapy nuclear factor-B status, chemoradiation resistance, and metastatic progression in esophageal carcinoma","volume":"5","author":"Izzo","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.canrad.2015.04.004_bib0270","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1756-9966-29-100","article-title":"TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil\/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma","volume":"29","author":"Kuwahara","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.canrad.2015.04.004_bib0275","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2168.2001.01670.x","article-title":"Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer","volume":"88","author":"Geh","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.canrad.2015.04.004_bib0280","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejso.2007.09.006","article-title":"Acute respiratory disease syndrome with preoperative chronomodulated chemoradiotherapy in patients with esophageal cancer. Early termination of a phase\u00a0I trial","volume":"34","author":"Adenis","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF02303535","article-title":"Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junction","volume":"1","author":"Sauter","year":"1994","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0290","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/S1278-3218(10)70010-X","article-title":"Cancer de l\u2019\u0153sophage","volume":"14","author":"Dupuis","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2015.04.004_bib0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijrobp.2009.04.053","article-title":"Influence of irradiated lung volumes on perioperative morbidity and mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer","volume":"77","author":"D\u00e4hn","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0300","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.meddos.2006.12.003","article-title":"Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution","volume":"32","author":"Chen","year":"2007","journal-title":"Med Dosim"},{"key":"10.1016\/j.canrad.2015.04.004_bib0305","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.athoracsur.2004.05.037","article-title":"ERBB2\u00a0amplifications in esophageal adenocarcinoma","volume":"78","author":"Dahlberg","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.canrad.2015.04.004_bib0310","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijrobp.2006.08.076","article-title":"Phase\u00a0I\/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2\u00a0overexpressing, esophageal adenocarcinoma","volume":"67","author":"Safran","year":"2007","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0315","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cncr.22445","article-title":"Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome","volume":"109","author":"Wang","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2015.04.004_bib0320","first-page":"430","article-title":"A phase\u00a0II trial of preoperative concurrent chemotherapy\/radiation therapy plus bevacizumab\/erlotinib in the treatment of localized esophageal cancer","volume":"10","author":"Bendell","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0325","unstructured":"Adenis A, Aparicio T, Bonnetain F, Dahan L, Guimbaud R, Mariette C, et al. \u00c9tude de phase\u00a0I\u2013II \u00e9valuant un traitement n\u00e9oadjuvant dans les cancers de l\u2019\u0153sophage op\u00e9rables par 5-fluorouracile, cisplatine et cetuximab avec radioth\u00e9rapie concomitante\u00a0: r\u00e9sultats pr\u00e9liminaires de la phase\u00a0II (FFCD 0505-PRODIGE\u00a03) [document sur Internet]. Disponible en ligne \u00e0 l\u2019adresse: http:\/\/www.snfge.org\/content\/etude-de-phase-i-ii-evaluant-un-traitement-neo."},{"key":"10.1016\/j.canrad.2015.04.004_bib0330","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1200\/jco.2011.29.15_suppl.4072","article-title":"Chemoradiation with FOLFOX plus cetuximab in locally advanced cardia or esophageal cancer: final results of a GERCOR phase\u00a0II trial (ERaFOX)","volume":"29","author":"Dahan","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2015.04.004_bib0335","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2014.05.022","article-title":"Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study","volume":"90","author":"Kordes","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181500116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S127832181500116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:24:25Z","timestamp":1761135865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832181500116X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S127832181500116X"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2015.04.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9sultats \u00e0 long terme de la chimioradioth\u00e9rapie n\u00e9oadjuvante des cancers de l\u2019\u0153sophage\u00a0: \u00e9tude r\u00e9trospective monocentrique sur 102\u00a0patients","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2015.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}